Fan, W., Zhu, B., Yue, S., Zheng, X., Zou, X., Li, F., . . . Li, J. (2023). Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis. Wiley.
Chicago Style (17th ed.) CitationFan, Wenzhe, et al. Idarubicin‐Loaded DEB‐TACE Plus Lenvatinib Versus Lenvatinib for Patients with Advanced Hepatocellular Carcinoma: A Propensity Score‐matching Analysis. Wiley, 2023.
MLA (9th ed.) CitationFan, Wenzhe, et al. Idarubicin‐Loaded DEB‐TACE Plus Lenvatinib Versus Lenvatinib for Patients with Advanced Hepatocellular Carcinoma: A Propensity Score‐matching Analysis. Wiley, 2023.
Warning: These citations may not always be 100% accurate.